Atlas Trials

Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?

Clinical trial NCT05359341 · COMPLETED

Trial details

NCT number
NCT05359341
Sponsor
Sadat City University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabete Type 2
Start date
2020-09-20
Primary completion
2021-09-20
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.